このエピソードについて

英語
アメリカ合衆国

文字起こし 🔗

過去のエピソードを検索

Dementia Mattersの以前のエピソードを検索します。

このポッドキャストの他のエピソード

Geriatrician Dr. Mark Supiano joins the podcast to discuss the connection between heart and brain health. Citing multiple clinical trials, he breaks down what these studies and their findings mean for blood pressure management’s effect on cognitive decline and how they directly impact both patients…
Dr. Jessen returns to the podcast to take a deeper dive into subjective cognitive decline (SCD). Aiming to cover everything relating to SCD, Dr. Jessen shares insights in prognosis, risk factors and how SCD should be addressed in research and clinical practice.  Guest: Frank Jessen, MD, professor …
Subjective cognitive decline (SCD) can be one of the earliest noticeable signs of Alzheimer's disease, yet SCD is not yet fully understood. To help us understand more, Dr. Frank Jessen, an expert in the field, joins the podcast to discuss how SCD is defined, classified, and evaluated in both clinic…
Guest host Dr. Art Walaszek takes over the podcast to interview Dr. Chin about his upcoming book, When Memory Fades. In addition to discussing the importance of dementia research and other clinical topics covered in the book, Dr. Chin shares what drew him to write When Memory Fades, what the writin…
Amyloid-targeting monoclonal antibody treatments have ushered in a new era of Alzheimer’s disease therapies after decades of research and clinical trials. A recent review published by Cochrane, a global, independent, non-profit network of researchers, professionals, patients and carers regarded as …
免責: このページに埋め込まれているポッドキャストとアートワークは Wisconsin Alzheimer‘s Disease Research Center からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。